NYSE: GSKGlaxosmithkline Plc Stock Ownership
Insider buying vs selling
Have Glaxosmithkline Plc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
GSK Shareholders
What type of owners hold Glaxosmithkline Plc stock?
Institutional
Insider
Retail
We're currently working to improve the accuracy of the Shareholders dataset. If you spot any inaccuracies, let us know at contact (at) wallstreetzen.com
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dodge Cox | 0.84% | 45,000,656 | $1.67B | Institution |
| Fmr LLC | 0.37% | 19,763,199 | $732.62M | Institution |
| Renaissance Technologies LLC | 0.34% | 18,329,654 | $679.48M | Institution |
| Price T Rowe Associates Inc | 0.33% | 17,688,257 | $655.70M | Institution |
| Capital International Investors | 0.31% | 16,505,150 | $611.85M | Institution |
| Fisher Asset Management LLC | 0.30% | 16,226,217 | $601.51M | Institution |
| Royal Bank Of Canada | 0.29% | 15,564,595 | $576.98M | Institution |
| State Street Corp | 0.17% | 9,390,232 | $348.10M | Institution |
| Hotchkis Wiley Capital Management LLC | 0.14% | 7,404,500 | $274.48M | Institution |
| Black Creek Investment Management Inc | 0.12% | 6,485,876 | $240.43M | Institution |
Glaxosmithkline Stock Ownership FAQ
Who owns Glaxosmithkline?
Glaxosmithkline (NYSE: GSK) is owned by 5.52% institutional shareholders, 0.00% Glaxosmithkline insiders, and 94.48% retail investors. Dodge Cox is the largest individual Glaxosmithkline shareholder, owning 45.00M shares representing 0.84% of the company. Dodge Cox's Glaxosmithkline shares are currently valued at $1.67B.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
